TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Fidia Spa ( (IT:FDA) ) just unveiled an announcement.
Fidia S.p.A. announced the conversion of five bonds into 357,142 new shares by Global Growth Holding Limited, as part of a convertible bond loan with warrants. This conversion increases Fidia’s share capital by Euro 50,000, bringing the total number of shares to 20,405,881. The move reflects Fidia’s ongoing capital restructuring efforts to enhance its market position and operational capacity.
The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.50 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.
More about Fidia Spa
Fidia S.p.A., based in Turin and listed on the Euronext Milan market, is a global leader in the design, production, and marketing of high-performance integrated milling systems. The company primarily serves the automotive and aerospace sectors, offering comprehensive solutions for the entire milling process, including numerical controls, high-speed milling systems, and CAM software.
Average Trading Volume: 600,624
Technical Sentiment Signal: Strong Sell
Current Market Cap: €3.61M
Learn more about FDA stock on TipRanks’ Stock Analysis page.

